Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms dMCL1-6 |
Target |
Action degraders, inhibitors |
Mechanism Mcl-1 degraders(Induced myeloid leukemia cell differentiation protein Mcl-1 degraders), Mcl-1 inhibitors(Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC63H67N9O12 |
InChIKeyJZQOTODZTIWWFI-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Canada | 22 May 2019 |